RPL3L and cardiomyopathy: Additionally, predicted loss-of-function (pLOF) variants in RPL3l are associated with an increased risk of atrial fibrillation and cardiomyopathy, highlighting its potential role in cardiac rhythm regulation and myocardial remodeling (77).